Urinary androgen response of 8 girls with precocious puberty given cyproterone acetate.
The effects of cyproterone acetate (CA), daily oral administration of 100 mg/m2, on the levels of urinary androgen excretion and velocity of skeletal maturation were studied in 8 girl patients with precocious puberty. Under therapy, testosterone excretion fell within a short time, and velocity of skeletal maturation normalized when the treatment was prolonged. Other beneficial effects such as stoppage of vaginal bleeding and no further growth of breast size and public hair, were also observed. Of 3 subjects, who were given CA for a period of 2--3 yrs, 2 showed further increments in testosterone excretion levels.
D000728:Androgens / Q000652:urine*; D001846:Bone Development / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D003534:Cyproterone / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D011629:Puberty, Precocious / Q000188:drug therapy*
D000728:Androgens; D003534:Cyproterone